InforMedix Holdings, Inc. (OTCBB: IFMX, http://www.informedix.com/), developer of the Med-eMonitor™ System for medication adherence and health management, has retained Bruce Kneeland to serve as Vice President of Pharmacy Product Leasing.
Kneeland, 60, arrives with an impressive background in launching new product lines through pharmacies. Since 2002, he has served as the Founder and Principal Consultant of PharmacyConnections, which provides strategic planning, fosters client relations, generates contracted sales, and implements marketing services across the drug store industry. Kneeland’s prior positions include Vice President Retail Sales and Marketing with AmerisourceBergen (NYSE: ABC), Vice President Marketing and Communications for the Healthcare Distribution Management Association (HDMA), VP Franchise Sales for Health Mart, Inc., and Regional Operations Manager for Medicine Shoppe International. Kneeland’s professional efforts were recognized in 2003 with the Pennsylvania Pharmacists Association’s Pharmaceutical Industry Person of the Year Award.
“Bruce has devoted his career to implementing new service programs and launching new products through pharmacies,” said Bruce A. Kehr, MD, Chief Executive Officer and Chairman of InforMedix. “We are extremely excited to gain the benefit of his knowledge and industry connections as we launch our Med-eMonitor System through our pharmacy channel partners, who collectively have almost six hundred stores under their umbrella.”
About InforMedix, Inc.
InforMedix, Inc., based in Rockville, Maryland, has developed the Med-eMonitor System as The Medication Adherence Solution for consumer product and disease management markets, to deliver peace-of-mind, improved independent living, and better health outcomes to patients and their loved ones. The Med-eMonitor System (“Medication, Safe and Easy™”) integrates a portable patient-interactive “smart pillbox,” hardware, software, and 24/7 monitoring. This is designed to enable chronically ill patients and their loved ones, and professionals in disease management programs, to efficiently monitor and manage Med-eMonitor users’ medication and care plan adherence, clinical response, and drug safety. InforMedix has recently signed cooperative agreements that include almost six hundred pharmacies in Alabama, Arkansas, Kentucky, Louisiana, Massachusetts, Mississippi, Missouri, Oklahoma, Tennessee, Texas, and Washington, D.C. For more information, visit http://www.informedix.com.
Safe Harbor Statement
This press release may contain forward looking statements that involve risks and uncertainties, including statements regarding our business strategy, development plans, and distribution plans for entering into new businesses, anticipated sources and uses of funds, anticipated sales of our products and other statements regarding our plans, objectives, expectations and intentions that are not historical facts. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those discussed in this press release. These risks and uncertainties are described in greater detail in the reports that we file with the Securities and Exchange Commission. Our actual results, performance or achievements may vary materially from those expressed or implied in any forward-looking statements. All forward-looking statements reflect our beliefs and expectations as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise.
Contacts:
Mike Graff/ Susan Morgenbesser,
212-825-3210
mgraff@investorrelationsgroup.com
susan@invetsorrelationsgroup.com
